A spinal infection with Staphylococcus pseudintermedius

Christopher A Darlow1, Nikolaos Paidakakos2, Murtuza Sikander2

  • 1Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

BMJ Case Reports
|August 9, 2017
PubMed

Insights

This case report details a rare invasive spinal infection caused by Staphylococcus pseudintermedius, a bacterium typically found in animals. Prompt treatment, similar to Staphylococcus aureus infections, led to successful recovery.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Clinical Case Report

Background:

  • Spinal infections can be severe and challenging to treat.
  • Staphylococcus pseudintermedius is an emerging pathogen with zoonotic potential.
  • The identification of microorganisms is crucial for effective treatment.

Observation:

  • A 60-year-old woman presented with an invasive spinal infection linked to a long-standing spinal fixation device and contact with dogs.
  • Blood and epidural abscess pus cultures confirmed Staphylococcus pseudintermedius.
  • The patient developed a deep abscess, a previously unreported presentation for this organism.

Findings:

  • The infection was successfully treated with a regimen of intravenous flucloxacillin followed by oral clindamycin, mirroring treatment protocols for Staphylococcus aureus infections.
  • Matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) technology facilitated the specific identification of Staphylococcus pseudintermedius.
  • This case is the first reported instance of a deep abscess caused by Staphylococcus pseudintermedius.

Implications:

  • Staphylococcus pseudintermedius poses a zoonotic risk and can cause invasive infections in humans.
  • Standard treatment protocols for Staphylococcus aureus infections appear effective against Staphylococcus pseudintermedius.
  • Advances in microbial identification techniques are revealing previously unrecognized pathogens and their clinical significance.